What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - Common Stock in Q1 2017?

134 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - Common Stock for Q1 2017. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Common Stock
Shares outstanding: 59,119,327
Total 13F shares: 39,704,878
Share change: +3,360,965
Total reported value: $555,846,956
Put/Call ratio: 157%
Price per share: $14.00
Number of holders: 134
Value change: +$44,096,425
Number of buys: 66
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Palo Alto Investors LP	13F	Company	7.1%	4,203,270	$67,042,000	—	31 Dec 2016	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5.8%	3,424,676	$54,624,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	3.8%	2,270,297	$36,211,000	—	31 Dec 2016	13F
GREAT POINT PARTNERS LLC	13F	Company	3.4%	2,010,000	$32,060,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	3.3%	1,972,678	$31,464,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	3%	1,786,540	$28,496,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	3%	1,751,605	$27,935,000	—	31 Dec 2016	13F
MACQUARIE GROUP LTD	13F	Company	2.3%	1,372,640	$21,894,000	—	31 Dec 2016	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.3%	1,370,655	$21,863,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	2.1%	1,224,332	$19,528,000	—	31 Dec 2016	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	1,021,171	$16,288,000	—	31 Dec 2016	13F
FMR LLC	13F	Company	1.7%	996,271	$15,891,000	—	31 Dec 2016	13F
AJO, LP	13F	Company	1.4%	804,206	$12,827,000	—	31 Dec 2016	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	1.3%	757,507	$12,082,000	—	31 Dec 2016	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1%	609,618	$9,723,000	—	31 Dec 2016	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.99%	583,960	$9,314,000	—	31 Dec 2016	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.98%	580,000	$9,251,000	—	31 Dec 2016	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.96%	568,350	$9,065,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.9%	530,681	$8,464,000	—	31 Dec 2016	13F
EverPoint Asset Management, LLC	13F	Company	0.89%	525,000	$8,374,000	—	31 Dec 2016	13F
Numeric Investors LLC	13F	Company	0.84%	496,600	$7,921,000	—	31 Dec 2016	13F
Invesco Ltd.	13F	Company	0.83%	488,025	$7,784,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.82%	484,552	$7,729,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.8%	472,909	$7,542,000	—	31 Dec 2016	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.76%	450,847	$7,191,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.73%	434,303	$6,928,000	—	31 Dec 2016	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.71%	418,732	$6,679,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.66%	389,278	$6,209,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.66%	388,583	$6,197,000	—	31 Dec 2016	13F
Russell Investments Group, Ltd.	13F	Company	0.65%	384,810	$6,196,000	—	31 Dec 2016	13F
Avoro Capital Advisors LLC	13F	Company	0.65%	381,466	$6,084,000	—	31 Dec 2016	13F
QS Investors, LLC	13F	Company	0.59%	351,241	$5,602,000	—	31 Dec 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.56%	333,619	$5,322,000	—	31 Dec 2016	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.48%	282,292	$4,502,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.45%	263,800	$4,206,000	—	31 Dec 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.42%	249,028	$3,972,000	—	31 Dec 2016	13F
S.c.a. Candriam	13F	Individual	0.4%	237,000	$3,780,000	—	31 Dec 2016	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.36%	215,275	$3,434,000	—	31 Dec 2016	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.33%	196,066	$3,127,000	—	31 Dec 2016	13F
CREDIT SUISSE AG/	13F	Company	0.32%	186,556	$2,975,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.31%	185,892	$2,965,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.3%	180,312	$2,876,000	—	31 Dec 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.28%	165,959	$2,647,000	—	31 Dec 2016	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.28%	162,600	$2,593,000	—	31 Dec 2016	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.27%	160,800	$2,565,000	—	31 Dec 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.26%	156,183	$2,491,000	—	31 Dec 2016	13F
Point72 Asset Management, L.P.	13F	Company	0.26%	151,100	$2,410,000	—	31 Dec 2016	13F
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC.	13F	Company	0.25%	148,900	$2,374,000	—	31 Dec 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.25%	148,170	$2,363,000	—	31 Dec 2016	13F
AXIOM INVESTORS LLC /DE	13F	Company	0.25%	147,776	$2,357,000	—	31 Dec 2016	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q1 2017

As of 31 Mar 2017, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,704,878 shares. The largest 10 holders included Palo Alto Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., DEERFIELD MANAGEMENT CO, GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, FMR LLC, MORGAN STANLEY, and STATE STREET CORP. This page lists 134 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

141

Q1 2017 holders

134

Holder diff

-7

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.